Introduction
Translational control has a major role in regulating gene expression and occurs primarily at the initiation step involving multiple eukaryotic translation initiation factors (eukaryotic initiation factors (eIFs)) (Mathews et al., 2000; Dong and Zhang, 2006) . eIF3a, the largest subunit of the eIF3 complex, has been suggested to have roles in regulating translation of a subset of mRNAs, and in regulating cell-cycle progression and cell proliferation (Dong and Zhang, 2006; Dong et al., 2009) . Suppressing endogenous eIF3a expression has been shown to reverse the malignant phenotype of human cancer cells (Dong et al., 2004) , whereas overexpression of ectopic eIF3a has been shown to promote malignant transformation of mammalian cells . eIF3a expression has also been correlated with better prognosis of human cancer patients, and eIF3a upregulation in lung cancer patients correlates with their response to platinum-based chemotherapy and contributes to increased cisplatin (cis-dichlorodiammine platinum(II) (CDDP)) sensitivity (Yin et al., 2011b) . These observations suggest that eIF3a has an important role in tumorigenesis and in cancer cell response to chemotherapeutics, possibly by regulating gene expression.
Nasopharyngeal carcinoma (NPC) has a high incidence rate in South China, although being rare in other parts of the world. The first treatment choice for NPC is radiation therapy, which has yielded satisfactory outcomes in the early stage of NPC (Xiao et al., 2009 ). However, B70% of patients with newly diagnosed NPC present with locally advanced, non-metastatic, stage-III or IV diseases (Agulnik and Siu, 2005) , and experience poor prognosis from radiation therapy, with a 5-year overall survival rate varying from 37 to 61% (Agulnik and Siu, 2005; Afqir et al., 2009) . Concurrent chemoradiotherapy is now considered a standard treatment approach for locally advanced NPC, and CDDP-based regimen has been identified as the best protocol by metaanalysis (Thephamongkhol et al., 2004; Baujat et al., 2006) . Compared with radiotherapy alone, combination of CDDP-based chemotherapy with radiation improved 5-year overall survival by 6% (from 56 to 62%) and 5-year disease-free survival by 10% (from 42 to 52%) for locally advanced NPC (Baujat et al., 2006) . Unfortunately, many NPC patients do not benefit much from the concurrent chemoradiotherapy, possibly because of variation in treatment responses and CDDP resistance. Clearly, determining the underlying mechanisms of chemosensitivity/resistance in NPC will likely help in predicting potential responses of NPC patients for better clinical outcome, with less toxicity to the patients.
Toward this aim, we have selected a CDDP-sensitive S16 clone from an NPC cell line through limited dilution, and demonstrated that eIF3a expression is increased and contributes to CDDP sensitivity in the S16 clone. Knocking down eIF3a expression in S16 cells upregulates cellular nucleotide excision repair (NER) activity through increase in the synthesis rate of NER proteins such as xeroderma pigmentosum complementation group-A (XPA), XPC, radiation sensitive mutant 23 homolog B (RAD23B) and replication protein-A (RPA). These observations suggest that eIF3a may be a major candidate contributing to the CDDP sensitivity of NPC, and implicates that eIF3a may be used as a biomarker in predicting treatment outcome of CDDPbased chemotherapy for locally advanced NPC.
Results
Selection and characterization of a CDDP-sensitive clone S16 from NPC CNE-2 cells Previously, stepwise selections with anticancer drugs have been used as a standard method to create model cell lines for laboratory studies of acquired drug resistance. However, tumor heterogeneity could be a natural intrinsic cause of resistance (or sensitivity) in response to drug treatment. To investigate the mechanism of CDDP sensitivity/resistance of NPC cells, we performed a study using an approach different from the standard stepwise drug selection, and involving clonal selection from limited dilution. Using this approach, a CDDP-sensitive clone, S16, was selected from the parental CNE-2 cell line. S16 is approximately threefold more sensitive to CDDP than the parental CNE-2 cells, with an IC 50 of 2.5 ± 0.31 mM for S16 versus 8.7 ± 0.75 mM for CNE-2 ( Figure 1a) .
To verify that the S16 clone authentically originated from CNE-2, we examined their p53 mutation and short tandem repeat (STR) profiles. Both S16 and CNE-2 harbor an identical point mutation at codon-280 (exon-8) of p53, with a change of AGA (arginine) to ACA (threonine). The STR profiles of CNE-2 and S16 cells are also the same, except lost allele 216 at the D21S11 locus for S16 cells (Supplementary Table S1 ), showing a Figure 1 Characterization of the CDDP (cisplatin)-sensitive CNE-2 derivative sub-line S16 cells. (a) Survival assay. S16 and its parental CNE-2 cells were treated with various concentrations of CDDP for 72 h, followed by MTT assay for cell survival. (b, c) Apoptosis assay. S16 and its parental CNE-2 cells were pretreated with or without 30 mM pan-caspase inhibitor z-VAD-fmk 2 h before treatment with CDDP at 8.7 mM for 24 or 48 h, followed by DAPI staining of nuclei and imaging analysis as described in Materials and Methods. The yellow arrows indicate apoptotic cells. Scale bar, 25 mm. (c) Statistical analysis of apoptotic cells generated from three independent experiments. CDDP, cis-dichlorodiammine platinum(II); DAPI, 4,6-diamidino-2-phenylindole; MTT, (3-(4,5-dimethylthiazol-2-yl)-2,5)-diphenyltetrazolium bromide.
spontaneous genetic alteration that can be common in cancer cell lines. These findings suggest that S16 is likely derived from CNE-2 but with an increased sensitivity to CDDP.
To determine whether the increased CDDP sensitivity of S16 cells is due to increases in CDDP-induced apoptosis, S16 and its parental cell line CNE-2 were treated with CDDP at 8.7 mM for 24 and 48 h, followed by DAPI (4,6-diamidino-2-phenylindole) staining analysis of disintegrated nuclei, an indicator of apoptosis. As shown in Figures 1b and c, S16 cells have significantly more cells with disintegrated nuclei compared with CNE-2 cells at both 24 and 48 h of CDDP treatment. The CDDP-induced apoptosis can be reversed by pretreatment with z-VAD-fmk, a broad-spectrum caspase inhibitor. These observations suggest that S16 cells are more sensitive to CDDP-induced apoptosis than its parental CNE-2 cells.
Contribution of eIF3a overexpression to CDDP sensitivity of S16 cells Previously, it has been shown that cervical and esophageal cancer patients with high eIF3a level have better relapse-free and overall survival compared with those with low eIF3a expression (Dellas et al., 1998; Chen and Burger, 1999) . As CDDP is a primary anticancer drug for treating these cancers, it is conceivable that eIF3a may contribute to the CDDP response of these cancers. Indeed, it was recently found that eIF3a upregulation in lung cancer patients correlated with their response to platinum-based chemotherapy and contributed to increased CDDP sensitivity (Yin et al., 2011b) . On the basis of these previous observations, we propose that eIF3a expression may be upregulated in S16 cells compared with CNE-2, and therefore contributes to the increased CDDP sensitivity of S16 cells.
To test this hypothesis, we first examined the eIF3a expression level in S16 and CNE-2 cells using western blot analysis. As shown in Figure 2a , S16 cells clearly have more eIF3a than CNE-2 cells. We next examined whether the upregulated eIF3a expression possibly contributes to the increased CDDP sensitivity of S16 cells by knocking down eIF3a expression in S16 cells, followed by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. As shown in Figure 2b , eIF3a is successfully knocked down as determined using western blot analysis. S16 cells with reduced eIF3a expression are also more resistant to Figure 2 Contribution of eIF3a overexpression to the CDDP (cisplatin) sensitivity of S16 cells. (a) eIF3a expression in S16 and CNE-2 cells. CNE-2 and S16 cells in the logarithmic growth phase were collected and lysed, followed by western blot analysis of eIF3a and actin loading control. (b, c) Effect of eIF3a knockdown or ectopic overexpression on CDDP sensitivity. S16 cells (b) transiently transfected with an eIF3a siRNA (Si) or scrambled control siRNA (Scr), or CNE-2 cells (c) with stable eIF3a overexpression (eIF3a) or transfected with a vector control (Vec), were analyzed for their eIF3a expression level (inset) and CDDP response as described in Materials and Methods. (d) Relative resistance factor (RRF) was derived by dividing the IC 50 of the cells with eIF3a knockdown (for S16 cells) or overexpression (for CNE-2 cells) by that of the control cells generated from 3-5 independent experiments (**Po0.01). CDDP, cis-dichlorodiammine platinum(II); eIF3, eukaryotic initiation factor-3a; RRF, relative resistance factor; siRNA, small interfering RNA.
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R-Y Liu et al CDDP than control cells transfected with scrambled small interfering RNA (siRNA; Figure 2b ), with B3.5-fold increase in the relative resistance factor (RRF) as determined using MTT assay ( Figure 2d ). Similar results were also observed using colony formation assay (data not shown), eliminating the possible contribution of cell proliferation to drug sensitivity. Thus, the upregulated eIF3a level likely contributes to the increased CDDP sensitivity of S16 cells compared with its parental CNE-2 cells. To confirm the above conclusion, we next conducted a reverse experiment by increasing eIF3a expression in the parental CNE-2 cells and determined whether the increased eIF3a level would cause increased CDDP sensitivity in CNE-2 cells. For this purpose, a pool of stable CNE-2 cells transfected with eIF3a cDNA for ectopic eIF3a overexpression was selected and subjected to MTT assay ( Figure 2c ). It was found that the CNE-2 cells with stable eIF3a overexpression were more sensitive to CDDP, with a twofold decrease in RRF compared with that in control cells transfected with a vector (Figure 2d ). Taken together, we conclude that eIF3a overexpression contributes to the increased CDDP sensitivity of S16 cells.
The contribution of eIF3a to CDDP sensitivity is not cell line specific To rule out the possibility that the contribution of eIF3a to CDDP sensitivity is specific to CNE-2 and its derivative cell lines, we next tested another NPC cell line, SUNE-1, by knocking down eIF3a expression, followed by MTT assay. For this experiment, we also included the parental CNE-2 cell line to determine whether knocking down eIF3a expression would further increase its CDDP resistance. As shown in Figure 3a , eIF3a expression is successfully knocked down by siRNA in both cell lines as determined using western blot analysis. Both cell lines with reduced eIF3a level are also more resistant to CDDP (Figure 3b) , with an approximately twofold increase in RRF compared with that in their respective control cells transfected with scrambled siRNA (Figure 3c ). Thus, the role of eIF3a in CDDP sensitivity is likely not cell line -specific, and decreasing its level in the parental resistant CNE-2 cells could further increase its CDDP resistance.
The upregulated eIF3a level contributes to the increase in the CDDP-induced apoptosis of S16 cells As discussed above, S16 cells have an increased sensitivity to CDDP-induced apoptosis compared with their parental CNE-2 cells (Figure 1 ). To determine whether eIF3a upregulation mediates this process, we first examined whether knocking down the eIF3a level in S16 cells would reduce CDDP-induced apoptosis by analysis of disintegrated nuclei as described above. As shown in Figure 4a , S16 cells transfected with eIF3a siRNA clearly have significantly less apoptosis following CDDP treatment than control cells transfected with scrambled siRNA. We next examined the cleavage of Figure 3 Role of eIF3a in the CDDP (cisplatin) response of NPC cell lines SUNE-1 and CNE-2. SUNE-1 and CNE-2 cells were transiently transfected with eIF3a siRNA (Si) or scrambled control siRNA (Scr), followed by western blot analysis of eIF3a expression (a) and MTT assay of cellular response to CDDP (b). (c) Shown is the RRF derived by dividing IC 50 of the cells with eIF3a knockdown by that of the control cells from 3-5 independent experiments (**Po0.01). CDDP, cis-dichlorodiammine platinum(II); eIF3, eukaryotic initiation factor-3a; MTT, (3-(4,5-dimethylthiazol-2-yl)-2,5)-diphenyltetrazolium bromide; NPC, nasopharyngeal carcinoma; RRF, relative resistance factor; siRNA, small interfering RNA.
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PARP, a 115-kDa protein substrate of caspases, during execution of apoptosis. Cleavage of PARP by caspases yields an 85-kDa fragment. As shown in Figure 4b , S16 cells transfected with eIF3a siRNA generate much less cleaved 85-kDa PARP product than the control cells, following CDDP treatment. Thus, the upregulated eIF3a level in S16 cells likely mediates the increase in CDDP-induced apoptosis of S16 cells compared with its parental CNE-2 cells. eIF3a downregulates NER activity and expression of NER proteins CDDP causes cytotoxicity by causing DNA damages with the formation of CDDP-DNA adducts. To survive this DNA damage, cells mainly use nucleotide excision repair (NER) to remove the CDDP-DNA adducts. Thus, we hypothesize that eIF3a expression may reduce NER activity, which in turn increases CDDP sensitivity and CDDP-induced apoptosis. To test this hypothesis, we first examined whether eIF3a expression affects cellular response to UV treatment, which causes DNA damages that are also repaired by NER. For this purpose, S16 cells transfected with eIF3a or scrambled control siRNA were subjected to UV treatment, followed by analysis of apoptosis using ELISA. As shown in Figure 4c , S16 cells transfected with eIF3a siRNA are significantly more resistant to UV-induced apoptosis than control cells at both 30 and 60 J/cm 2 . Next, the effect of knockdown of eIF3a expression in S16 cells on NER activity was determined using host-cell reactivation assay (Qiao et al., 2002) . For this purpose, a plasmid containing a luciferase reporter was first UVirradiated to generate DNA adducts. The damaged reporter plasmids were then transfected into S16 cells with reduced eIF3a expression, followed by analysis of luciferase activity, on the basis of the assumption that the damaged reporter plasmid will express luciferase only after its UV-induced damages are repaired by the cellular NER mechanism (Qiao et al., 2002) . As shown in Figure 5a , knocking down eIF3a expression significantly increases NER activities by B1.5-fold. Thus, the upregulated eIF3a expression in S16 cells likely suppresses cellular NER activity, which in turn contributes to the increased sensitivity to CDDP or UVinduced apoptosis. Figure 4 Effect of eIF3a knockdown on DNA damage-induced apoptosis. S16 cells were transiently transfected with eIF3a siRNA (Si) or scrambled control siRNA (Scr), followed by treatment with CDDP (a, b) or UV (c) at the indicated doses, and analysis of apoptosis by Hoechst-33342 staining for disintegrated nuclei (a), detection of cleaved PARP by western blotting (b) or Cell Death Detection ELISA kit (c) as described in Materials and Methods. The histograms shown are from three independent experiments (*Po0.05; **Po0.01). CDDP, cis-dichlorodiammine platinum(II); DAPI, 4,6-diamidino-2-phenylindole; eIF3, eukaryotic initiation factor-3a; MTT, (3-(4,5-dimethylthiazol-2-yl)-2,5)-diphenyltetrazolium bromide; RRF, relative resistance factor; siRNA, small interfering RNA. Figure 5 Effect of eIF3a knockdown on NER activity and expression of NER proteins. S16 cells were transiently transfected with eIF3a siRNA (Si) or scrambled control siRNA (Scr), followed by analysis of NER activity using HCR assay (a); expression of eIF3a, XPA, XPC, RPA32 and RAD23B using western blot analysis (b) and real time RT-PCR (c) analyses as described in Materials and Methods. Actin was used as a loading control for western blot analysis and GAPDH was used as an internal standard for real-time RT-PCR analyses. The histograms shown are from three independent experiments (**Po0.01). eIF3, eukaryotic initiation factor-3a; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HCR, host cell reactivation; NER, nucleotide excision repair; RPA, replication protein-A; RT-PCR, reverse transcription-PCR; siRNA, small interfering RNA; XPA, xeroderma pigmentosum complementation group-A.
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R-Y Liu et al NER represents one of the known major DNA repair mechanisms and involves several key DNA repair proteins (Sancar et al., 2004; Zou et al., 2006) . Because eIF3a has been previously shown to have important roles in regulating gene expression by controlling protein synthesis (Dong and Zhang, 2006; Yin et al., 2011a) , we hypothesize that the increased eIF3a level in S16 cells likely downregulates the synthesis of NER proteins, which in turn downregulates NER activity. To test this hypothesis, we first determined the effect of eIF3a on the expression of NER proteins following eIF3a knockdown using western blot analysis. As shown in Figure 5b , knocking down eIF3a expression clearly increases the level of key NER proteins XPA, XPC, RPA32 and RAD23B. However, the mRNA level of these NER proteins is not affected by knocking down eIF3a expression (Figure 5c) . Thus, the effect of eIF3a on the expression of NER proteins is likely at their protein levels.
To further determine whether eIF3a possibly regulates the synthesis but not the stability of these representative NER proteins, we performed pulse-chase and pulse labeling in combination with immunoprecipitation and autoradiography to measure the synthesis rate and half-life of these NER proteins. As shown in Figure 6 , eIF3a knockdown in S16 cells has no effect on the half-life of these NER proteins, but significantly increases their synthesis rate as determined in pulsechase and pulse labeling experiments, respectively. Taken together, these findings suggest that eIF3a negatively regulates the synthesis of NER proteins by suppressing the translation of their mRNAs without affecting their transcription to produce mRNAs, nor the stability (or degradation) of these proteins. It is noteworthy that the degradation of these NER proteins may occur differently, with XPA and XPC in a bi-phase, whereas RPA32 and RAD23B in a mono-phase mode. Regardless, eIF3a does not appear to have any effect on their degradation.
Discussion
In this study, we have successfully selected a CDDPsensitive NPC cell clone, S16, from the CNE-2 cell line by limited dilution, and demonstrated that eIF3a overexpression contributes to increased CDDP sensitivity in S16 cells by suppressing synthesis of NER proteins, which, in turn, contributes to increase in CDDP-induced apoptosis and CDDP sensitivity. This outcome establishes eIF3a as a potential marker predicting CDDP responses and helping to guide future treatment of NPC patients. S16 cells appears to be generated authentically from CNE-2 possibly owing to spontaneous genetic changes. This argument is supported by the finding of only a partial incompatibility at the D21S11 locus between S16 and its parental CNE-2 cells. The finding of increased eIF3a expression also supports the above argument. However, it is currently unknown how eIF3a expression is upregulated in S16 cells. Previously, increased expression of eIF3a has been found in various human cancers compared with normal tissues (Bachmann et al., 1997; Dellas et al., 1998; Burger, 1999, 2004; Pincheira et al., 2001) . It is possible that the increased eIF3a expression in these systems uses similar mechanisms of upregulation. Future studies investigating the mechanism of regulation of eIF3a expression will be beneficial to address this issue. eIF3a was initially thought to be essential for global translation initiation process. However, accumulating evidences suggest that eIF3a may have a more important regulatory role in mRNA translation. It was first found that the eIF3 complex lacking eIF3a functioned without distinction from the eIF3 complex containing eIF3a in forming preinitiation complexes (Chaudhuri et al., 1997) . Later, it was found that knocking down eIF3a expression did not severely suppress global mRNA translation, but, in fact, it increased the synthesis of proteins such as p27 while suppressing the synthesis of ribonucleotide reductase M2 (Dong et al., 2004) . The finding reported in this paper that knocking down eIF3a increased the synthesis of NER proteins further enforces the possible regulatory role of eIF3a in translational control. Furthermore, we have also observed previously that knocking down or ectopically overexpressing eIF3a does not affect the expression of other putative eIF3 subunits, suggesting that the regulatory role of eIF3a may not involve a change in the expression of other putative eIF3 subunits (Dong et al., 2004) . Figure 6 Effect of eIF3a knockdown on the synthesis and half-life of NER proteins. S16 cells were transiently transfected with eIF3a siRNA (Si) or scrambled control siRNA (Scr), followed by pulse labeling with [ 35 S]methionine and preparation of cell lysate, or washed and chased in the presence of cold methionine for various time periods before preparation of cell lysate as described in Materials and Methods. The cell lysates were then subjected to immunoprecipitation of XPA, XPC, RPA32 and RAD23B, followed by separation by SDS-PAGE and autoradiaography of the gels. The insets show the results following pulse labeling (synthesis), and the curves show the results of chase (half-life). eIF3, eukaryotic initiation factor-3a; NER, nucleotide excision repair; RPA, replication protein-A; RT-PCR, reverse transcription-PCR; SDSPAGE, sodium dodecyl sulfatePAGE; siRNA, small interfering RNA; XPA, xeroderma pigmentosum complementation group-A.
It is still not yet understood how eIF3a participates in translational control. The finding that eIF3a possibly regulates the synthesis of a group of proteins in NER is also puzzling. Nevertheless, it has been suggested previously that the 5 0 -and 3 0 -untranslated regions of mRNAs under eIF3a regulation may mediate this regulatory process. For example, the 5 0 -and 3 0 -untranslated regions of p27 and ribonucleotide reductase M2 appeared to be responsible for eIF3a regulation of the translation of these genes (Dong et al., 2004) . Recently, it was found that the synthesis of phosphatase of regenerating liver-3 (PRL-3) was suppressed by polyC-RNA-binding protein-1 (PCBP1) through the binding of PCBP1 to a triple GCCCAG motif in the 5-untranslated region of PRL-3 mRNAs (Wang et al., 2010) . Thus, it is possible that the mRNAs under the regulation of eIF3a may have a consensus sequence motif in their untranslated regions that can possibly bind to eIF3a. This possibility is waiting to be tested.
CDDP is an anticancer drug used to treat many types of cancers, including nasopharyngeal, lung, ovarian, cervical and esophageal cancers. Unfortunately, lack of response to CDDP frequently occurs, which limits successes in the treatment of these cancers. Increase in DNA damage repair is one of the mechanisms of CDDP resistance (Siddik, 2003) . NER is the main pathway for the repair of CDDP-induced DNA damage (Nouspikel, 2009; Neher et al., 2010a, b) , which functions by recognizing DNA adducts through the XPC-RAD23B sub-complex and forming an NER complex through the binding of XPA, RPA and other proteins (Friedberg, 2001) . NER pathway defect results in cellular hypersensitivity to CDDP, and restoring NER activity will increase cellular resistance (Furuta et al., 2002; Siddik, 2003) . The current finding that eIF3a expression negatively regulates the expression of NER-related proteins (XPA, XPC, RAD23B and RPA) and contributes to CDDP sensitivity suggests that assessing eIF3a level may help predict CDDP responses and design individualized treatment strategies for patients with these cancers. Previously, it has been observed that cervical and esophageal cancer patients with a high eIF3a level had better relapse-free and overall survival than those with low eIF3a expression (Dellas et al., 1998; Chen and Burger, 1999) . As CDDP is a primary anticancer drug used for treating these cancers, it is conceivable that eIF3a may contribute to CDDP response in these cancer patients. It is also tempting to speculate that eIF3a expression may contribute to cellular response to CDDP in any cancers that are treated with this drug, and that assessing the eIF3a level may help predict response and design treatment strategies for these cancers.
Materials and methods

Materials
Rabbit polyclonal IgGs against XPA, XPC, RPA32, RAD23B, as well as eIF3a siRNA, were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). 
Cell lines, characterization and transfection
Human NPC cell lines CNE-2 and SUNE-1 were maintained in DMEM containing 10% fetal bovine serum and maintained in a humidified atmosphere with 5% CO 2 at 37 1C. S16, a CDDP-sensitive sub-clone derived from CNE-2, was isolated by limited dilution as previously described (Qian et al., 2006) , and was maintained similarly as the parental CNE-2 cells.
For STR profile analysis, six STR loci, HUMTHO1, HUMvWA, D18S51, D20S85, D21S11 and HPRTB, were examined. The primers for the first five STR loci were designed according to a previous report (Oldroyd et al., 1995) , with the forward primers labeled with FAM (for HUMTHO1, HUMVWFA31/A, D18S51 and D21S11 loci) or HEX (for D20S85 locus). HPRTB, a tetranucleotide repeat at chromosome Xq26.1, was amplified with an FAM-labeled forward primer (5 0 -FAM-ATGCCACAGATAATACACATCCCC-3 0 ) and an unlabeled reverse primer (5 0 -CTCTCCAGAATAGT TAGATGTAGG-3 0 ). PCR was performed using AmpliTaq Gold polymerase. One microliter of each PCR product was added to 5 ml of DNase-free, RNase-free distilled water, 10 ml of Hi-Di formamide and 0.2 ml of ROX 400HD size standard, and denatured at 95 1C for 5 min before loading the samples into an ABI Prism 3700 Genetic Analyzer (Applied Biosystems). Analysis of raw data was performed using the Genescan v3.7 software (Applied Biosystems). For p53 mutation analysis, 1 mg of cellular total RNA was reverse-transcribed into cDNA with Superscript II reverse transcriptase. p53 fulllength cDNA was obtained by consequent PCR and sequenced for mutant analysis.
For transient transfection, cells were seeded in a 10-cm dish and cultured for 24 h before transfection with eIF3a or scrambled control siRNAs (200B400 pmol per dish) using Lipofectamine-2000 transfection reagent according to the manufacturer's instructions. The cells were cultured for an additional 24 h and were harvested for further analysis. To generate stable CNE-2 cells with overexpression of ectopic eIF3a, CNE-2 cells were seeded in a 6-cm dish and cultured for 24 h, and then were transfected with the eIF3a expression plasmid pCbA-p170 (Dong and Zhang, 2003) or a blank vector pCbA. Twenty-four hours after transfection, standard media were replaced with media containing G418. Stable transfected cell lines were obtained by selection in media containing 750 mg/ml G418 for 3 weeks, and then maintained in media containing 200 mg/ml G418.
Western blot analysis
Western blot analysis was performed as described previously (Dong et al., 2009) . Briefly, cells were harvested and lysed with TNN-sodium dodecyl sulfate (SDS) buffer (50 mM TrisHCl (pH 7.5), 150 mM NaCl, 50 mM NaF, 1 mM sodium orthovanadate, 1 mM dithiothreitol, 2 mM phenylmethylsulfonyl fluoride, 0.5% NP-40 and 0.1% SDS) at 4 1C for 30 min, followed by centrifugation (10 000 g for 10 min at 4 1C) to remove cell debris. The supernatants were collected and protein concentrations were measured, followed by separation by SDS-PAGE. The proteins were then transferred to polyvinylidene difluoride membranes, which were probed with specific primary antibodies, followed by reaction with relevant horseradish peroxidase-conjugated secondary antibodies and signal detection using the enhanced chemiluminescence system.
Real-time RT-PCR analysis
Real-time reverse transcription (RT)-PCR was performed as described previously (Dong et al., 2005) . Briefly, cells were harvested and total RNAs were extracted using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA) followed by real-time RT-PCR using the Power SYBR Green RNA-to-CT 1-Step kit and primers for each gene as listed in Supplementary  Table S2 . The threshold cycle (C t ) was determined and normalized against that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) internal control. The relative mRNA levels were shown as the value of 2 DCt . The changes in mRNA levels were presented as a ratio of relative mRNA level in the experimental group versus that in the control group.
Cytotoxicity and apoptosis assays Cytotoxicity of CDDP was determined using MTT and colony formation assays as described previously (Yang et al., 2002 (Yang et al., , 2007 Liu et al., 2006 Liu et al., , 2008 Xu et al., 2007; Li et al., 2010; Yin et al., 2011b) . Briefly, stable cell lines or cells harvested from transient transfection were cultured in 96-or 6-well plates for 24 h and then treated with CDDP at various concentrations for 3 days (MTT) or 8-11 days (colony formation). Viable cells were stained with MTT followed by determination of OD 570 nm at a reference wavelength at 630 nm, or staining with crystal violet for colony counting. The data were analyzed using GraphPad Prism 4 (GraphPad Software, La Jolla, CA, USA) to obtain the IC 50 . The RRF was calculated by dividing the IC 50 of cells with altered eIF3a expression by the IC 50 of control cells.
Analysis of apoptosis by DAPI or Hoechst-33342 staining of disintegrated nuclei was performed as described previously (Koo et al., 1999) . Briefly, both floating and adherent cells following CDDP treatment were harvested and stained with DAPI or Hoechst dye. The stained cells were mounted onto a polylysine-coated slide by centrifugation and examined under a fluorescent microscope. A total of 300-400 nuclei from five randomly chosen fields were examined and the nuclei displaying distinctive apoptosisassociated morphological changes were scored. Apoptosis was expressed as a percentage of the total number of nuclei examined.
Apoptosis was analyzed using the Cell Death Detection ELISA kit (Roche, Indianapolis, IN, USA) according to the manufacturer's instructions. Briefly, S16 cells were plated in a six-well plate at a density of 2.5 Â 10 5 cell per well and cultured for 24 h before being transfected with eIF3a or scrambled control siRNA. Forty-eight hours after transfection, media were replaced with fresh complete media and the cells were irradiated with various doses of UV light, followed by continuous culture for 24 h. The cells were then harvested and B1 Â 10 4 cells were lysed and analyzed for apoptosis. PARP cleavage, an indicator of apoptosis, was analyzed using western blot probed with an antibody that detects mainly the large fragment of cleaved PARP to avoid potential confusion from detection of uncleaved PARP.
Host-cell reactivation assay
The firefly luciferase assay-based host-cell reactivation assay was performed as previously described (Qiao et al., 2002) . Briefly, the pCMVluc plasmid (50 mg/ml) in a 48-well plate was UV-irradiated on ice using a Stratalinker UV Crosslinker (Stratagene, La Jolla, CA, USA). UV-induced damages were verified using PCR as previously described (Yin et al., 2011b) . The UV-damaged or unirradiated control plasmids (0.2 mg) were used to transfect 4 Â 10 4 cells in a 24-well plate using Lipofectamine. A pCMV-SPORT-bgal (Promega, Madison, WI, USA) plasmid encoding b-galactosidase was used as a control for transfection efficiency. Forty hours after transfection, cells were harvested for analysis of firefly luciferase and b-galactosidase activities as previously described (Dong et al., 2004) .
Pulse-chase and pulse labeling of cells Pulse-chase and pulse labeling of cells were performed as previously described (Dong and Zhang, 2003; Dong et al., 2004) . Briefly, the transiently transfected cells were cultured for an additional 48 h and washed twice with phosphatebuffered saline, once with DMEM lacking methionine, followed by incubation for 2 h in the same medium supplemented with 7.5 mCi/ml [ 35 S]methionine. The pulse-labeled cells were then washed three times with phosphate-buffered saline and harvested for cell lysate preparation and immunoprecipitation. To chase the labeling, cells were washed twice with phosphate-buffered saline and once with DMEM following the 2-h pulse-labeling step. The cells were then cultured in DMEM supplemented with 100 mg/ml cold methionine up to 8 h. After washing three times with phosphate-buffered saline, the cells were harvested for cell lysate preparation and immunoprecipitation.
Immunoprecipitation Following pulse-chase or pulse labeling, cells were harvested and lysed in TNN-SDS buffer without dithiothreitol, as described above. The lysates were then incubated with 1 mg of normal mouse IgG at 4 1C for 2 h, followed by incubation with 50 ml of 50% protein G-agarose slurry at 4 1C for an additional 3 h and centrifugation at 500 g for 5 min to remove nonspecific bound proteins. The supernatants were then incubated with 5 mg of primary antibodies against XPA, XPC, RAD23B and RPA32 at 4 1C for 2 h before mixing with 50 ml of protein G-agarose beads. The mixtures were incubated at 4 1C overnight followed by washing five times with lysis buffer. The final precipitates were separated by SDS-PAGE and signals were detected using autoradiography.
